Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H9NO2 |
| Molecular Weight | 151.1626 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC1=CC=CC(O)=C1
InChI
InChIKey=QLNWXBAGRTUKKI-UHFFFAOYSA-N
InChI=1S/C8H9NO2/c1-6(10)9-7-3-2-4-8(11)5-7/h2-5,11H,1H3,(H,9,10)
Metacetamol (3-hydroxyacetanilide) is a structural isomer of the widely used drug paracetamol and is being considered as a promising alternative to the latter because of its lower toxicity. 3-hydroxyacetanilide, the positional isomer of
paracetamol, does not cause depletion of GSH in vivo
or hepatotoxicity even though the
extent of covalent binding of the reactive metabolite
(in vivo or in vitro) is comparable to that for an
equimolar dose of paracetamol. Metacetamol should prove to be a useful tool to aid in the discrimination of hepatic acetaminophen protein adducts that may be critical or noncritical to survival of hepatocytes
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Differential regulation of mitogen-activated protein kinase pathways by acetaminophen and its nonhepatotoxic regioisomer 3'-hydroxyacetanilide in TAMH cells. | 2010-07 |
|
| Bioinformatic analysis of xenobiotic reactive metabolite target proteins and their interacting partners. | 2009-06-12 |
|
| Differential gene expression analysis of a known hepatotoxin, N-acetyl-p-amino-phenol (APAP) as compared to its non-toxic analog, N-acetyl-m-amino-phenol (AMAP) in mouse liver. | 2008-05 |
|
| Development of an HPLC-MS/MS method for the selective determination of paracetamol metabolites in mouse urine. | 2008-03-01 |
|
| Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. | 2007-09 |
|
| The reactive metabolite target protein database (TPDB)--a web-accessible resource. | 2007-03-16 |
|
| Genotoxic activities of aniline and its metabolites and their relationship to the carcinogenicity of aniline in the spleen of rats. | 2005-12 |
|
| Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites. | 2005 |
|
| Enzymatic synthesis of 3'-hydroxyacetaminophen catalyzed by tyrosinase. | 2003-12-06 |
|
| Cell culture model for acetaminophen-induced hepatocyte death in vivo. | 2002-08-01 |
|
| Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2. | 2001-11 |
|
| Identification of hepatic protein targets of the reactive metabolites of the non-hepatotoxic regioisomer of acetaminophen, 3'-hydroxyacetanilide, in the mouse in vivo using two-dimensional gel electrophoresis and mass spectrometry. | 2001 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Toxicity of meta or Metacetamol (3-hydroxyacetanilide) was evaluated in mice. The LD50 was 1025 mg/kg when given intraperitoneally (i.p.). The drug in doses greater than 400 mg/kg i.p. caused significant sedation. 3-Hydroxyacetanilide, 900 mg/kg i.p., did not cause hepatic necrosis evaluated by either histology or changes in plasma glutamate pyruvate transaminase activity.
The administration of acetyl-labeled [3H or 14C]3HAA (Metacetamol) (400 mg/kg, ip) produced levels of covalently bound radiolabel that were similar to those observed after an equimolar, hepatotoxic dose of [G-3H]acetaminophen.
Route of Administration:
Intraperitoneal
Metacetamol (3-hydroxyacetanilide), when incubated with liver
microsomes isolated from CS1 and DBA/2J mice,
co-factors and reduced glutathione (GSH) produced a dose-dependent depletion of GSH. 3-Hydroxyacetanilide (0.5 mM)
was a more potent depletor of GSH in vitro than was
paracetamol.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
210-687-0
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
621-42-1
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
100000081191
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
SUB08799MIG
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
76987
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
12124
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
C81395
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL9419
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
V942ZCN81H
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
DTXSID3022089
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
2701
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
3990
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY | |||
|
Metacetamol
Created by
admin on Wed Apr 02 08:42:35 GMT 2025 , Edited by admin on Wed Apr 02 08:42:35 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
